Search Results - "Nevill, T.J."

Improved Survival from Transfusion Dependence in Lower-Risk MDS Receiving Iron Chelation, Adjusting for MDS and Patient Characteristics: An MDS-Can Analysis by Leitch, H.A, Wells, R.A, Chodirker, L, Zhu, N, Nevill, T.J, Yee, K.W.L, Leber, B, Keating, M.M, Sabloff, M, Hilaire, E. St, Kumar, R, Delage, R, Geddes, M, Storring, J.M, Shamy, A, Elemary, M, Lenis, M, Francis, J, Zhang, L, Buckstein, R

Get full text

Outcome Of Elderly Patients With Acute Lymphoblastic Leukemia (EALL) With Chemotherapy: The Vancouver Experience by Tantiworawit, A, Barnett, M.J, Forrest, D.L, Hogge, D.E, Nantel, S.H, Narayanan, S, Nevill, T.J, Power, M.M, Shepherd, J.D, Smith, C.A, Song, K.W, Sutherland, H.J, Toze, C.L, Abou Mourad, Y.R

Get full text

283 - Improved Survival from Transfusion Dependence in Lower-Risk MDS Receiving Iron Chelation, Adjusting for MDS and Patient Characteristics: An MDS-Can Analysis by Leitch, H.A., Wells, R.A., Chodirker, L., Zhu, N., Nevill, T.J., Yee, K.W.L., Leber, B., Keating, M.M., Sabloff, M., Hilaire, E. St, Kumar, R., Delage, R., Geddes, M., Storring, J.M., Shamy, A., Elemary, M., Lenis, M., Francis, J., Zhang, L., Buckstein, R.

Get full text

Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens by Abou-Mourad, Y R, Lau, B C, Barnett, M J, Forrest, D L, Hogge, D E, Nantel, S H, Nevill, T J, Shepherd, J D, Smith, C A, Song, K W, Sutherland, H J, Toze, C L, Lavoie, J C

“…We analyzed the late outcomes of 429 long-term survivors post allogeneic hematopoietic SCT (allo-HSCT) who received transplant in our center between 1981 and…”
Get full text

298: Higher CD 34 Cell Doses Reduce Non Relapse Mortality (NRM) and do not Increase the Incidence of Graft Versus Host Disease (GVHD) following Unrelated Donor Blood Stem Cell Transplantation (SCT) by Narayanan, S, Barnett, M.J, Abou Mourad, Y.R, Forrest, D.L, Hogge, D.E, Lavoie, J.C, Nantel, S.H, Shepherd, J.D, Song, K.W, Sutherland, H.J, Toze, C.L, Smith, C.A, Power, M, Nevill, T.J

Get full text

Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes by Song, KW, Barnett, MJ, Gascoyne, RD, Chhanabhai, M, Forrest, DL, Hogge, DE, Lavoie, JC, Nantel, SH, Nevill, TJ, Shepherd, JD, Smith, CA, Sutherland, HJ, Toze, CL, Voss, NJ, Connors, JM

“…Background: Controversy exists regarding the role of high-dose therapy followed by stem-cell transplant (SCT) in the treatment of T-cell lymphoblastic lymphoma…”
Get full text

Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia by Halim, TY, Song, KW, Barnett, MJ, Forrest, DL, Hogge, DE, Nantel, SH, Nevill, TJ, Shepherd, JD, Smith, CA, Sutherland, HJ, Toze, CL, Lavoie, JC

“…Background: Curative intent chemotherapy for acute myelogenous leukemia (AML) leads to prolonged severe neutropenia, during which patients are highly…”
Get full text

Long-term follow-up of patients undergoing auto-SCT for advanced germ cell tumour: a multicentre cohort study by Seftel, M D, Paulson, K, Doocey, R, Song, K, Czaykowski, P, Coppin, C, Forrest, D, Hogge, D, Kollmansberger, C, Smith, C A, Shepherd, J D, Toze, C L, Murray, N, Sutherland, H, Nantel, S, Nevill, T J, Barnett, M J

“…Failure of cisplatin-based chemotherapy in advanced germ cell tumour (GCT) is associated with a poor outcome. High-dose chemotherapy and auto-SCT is one…”
Get full text

Allogeneic SCT for relapsed composite and transformed lymphoma using related and unrelated donors: long-term results by Ramadan, K M, Connors, J M, Al-Tourah, A J, Song, K W, Gascoyne, R D, Barnett, M J, Nevill, T J, Shepherd, J D, Nantel, S H, Sutherland, H J, Forrest, D L, Hogge, D E, Lavoie, J C, Abou-Mourad, Y R, Chhanabhai, M, Voss, N J, Brinkman, R R, Smith, C A, Toze, C L

“…Outcome is poor with conventional therapy for relapsed transformed non-Hodgkin's lymphoma (NHL). Autologous SCT has been successfully employed; however the…”
Get full text

Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML by Nevill, T J, Hogge, D E, Toze, C L, Nantel, S H, Power, M M, Abou Mourad, Y R, Song, K W, Lavoie, J C, Forrest, D L, Barnett, M J, Shepherd, J D, Nitta, J Y, Wong, S, Sutherland, H J, Smith, C A

“…Administration of alkylating agents (Alk), topoisomerase II inhibitors (Topo II) and radiotherapy (RT) can result in therapy-related myelodysplastic syndrome…”
Get full text

Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis by FORREST, D. L, NEVILL, T. J, SUTHERLAND, H. J, TOZE, C. L, DAVIS, J. H, HOGGE, D. E, NAIMAN, S. C, LE, A, BROCKINGTON, D. A, BARNETT, M. J, LAVOIE, J. C, NANTEL, S. H, SONG, K. W, SHEPHERD, J. D

“…To establish incidence and risk factors for development of second malignant neoplasms after high-dose chemo/radiotherapy (HDT) and autologous hematopoietic…”
Get full text

P-102 Use of blood stem cellsimproves results of allogeneic transplantation in patients with myelodysplastic syndrome/secondary acute myelogenous leukemia (MDS/SAML) and a poor-risk karyotype by Nevill, T.J., Sutherland, H.J., Song, K.W., Nantel, S.H., Hogge, D.E., Forrest, D.L., Lavoie, J.C., Toze, C.L., Barnett, M.J., Shepherd, J.D., Smith, C.A.

Get full text

Fulminant tumour lysis syndrome in acute myelogenous leukaemia with inv(16)(p13;q22) by Seftel, M.D., Bruyere, H., Copland, M., Hogge, D.E., Horsman, D.E., Nantel, S.H., Shepherd, J.D., Lavoie, J.C., Le, A., Sutherland, H.J., Toze, C.L., Nevill, T.J.

“…: Tumour lysis syndrome (TLS) is caused by rapid breakdown of malignant cells resulting in electrolyte disturbances and acute renal failure. TLS has rarely…”
Get full text

Acute Myelogenous Leukemia Complicated by Acute Necrotizing Ulcerative Gingivitis Due to Aspergillus terreus by Khoury, H., Poh, C.F., Williams, M., Lavoie, J.C., Nevill, T.J.

“…Infections caused by Aspergillus terreus are rare but have been associated with a poor outcome in immunocompromised patients due to frequent resistance to…”
Get full text

Allografting for indolent lymphoid neoplasms by Toze, C. L., Shepherd, J. D., Connors, J. M., Voss, N. J., Gascoyne, R. D., Hogge, D. E., Klingemann, H. G., Nantel, S. H., Nevill, T. J., Phillips, G. L., Reece, D. E., Sutherland, H. J., Conneally, E. A., Barnett, M. J.

“…Background: Allogeneic bone marrow transplantation (BMT) has been used in patients with low-grade lymphoma (LGL) and chronic lymphocytic leukemia (CLL) with…”
Get full text

The pharmacokinetics of oral cyclosporin a (neoral) during the first month after bone marrow transplantation by Schultz, K.R, Nevill, T.J, Toze, C.L, Corr, T, Currie, C, Strong, D.K, Keown, P.A

Get full text

Long-term outcome of allogeneic stem cell transplant: Single institution experience of a large cohort by Abou Mourad, Y.R., Lau, B.C.Y., Barnett, M.J., Forrest, D.L., Hogge, D.E., Nantel, S.H., Nevill, T.J., Shepherd, J.D., Smith, C.A., Song, K.W., Sutherland, H.J., Toze, C.C., Lavoie, J.C.

Get full text

Second solid cancers after allogeneic stem cell transplantation: The vancouver experience by Gallagher, G., Hogge, D.E., Nevill, T.J., Nantel, S.H., Barnett, M.J., Shepherd, J.D., Sutherland, H.J., Toze, C.L., Smith, C.A., Lavoie, J.C., Song, K.W., Forrest, D.L.

Get full text

123A-locus mismatch does not adversely influence outcome following related-donor stem cell transplantation (SCT) by Savoie, M.L., Sutherland, H.J., Hogge, D.E., Nantel, S.H., Toze, C.L., Lavoie, J.C., Sheperd, J.D., Song, K., Forrest, D., Nevill, T.J.

Get full text